[go: up one dir, main page]

AU2001230994A1 - Use of pentosan polysulfate to treat certain conditions of the prostate - Google Patents

Use of pentosan polysulfate to treat certain conditions of the prostate

Info

Publication number
AU2001230994A1
AU2001230994A1 AU2001230994A AU3099401A AU2001230994A1 AU 2001230994 A1 AU2001230994 A1 AU 2001230994A1 AU 2001230994 A AU2001230994 A AU 2001230994A AU 3099401 A AU3099401 A AU 3099401A AU 2001230994 A1 AU2001230994 A1 AU 2001230994A1
Authority
AU
Australia
Prior art keywords
prostate
certain conditions
pentosan polysulfate
treat certain
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230994A
Inventor
Gary E Striker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, Government of the United States of America filed Critical US Department of Health and Human Services
Publication of AU2001230994A1 publication Critical patent/AU2001230994A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001230994A 2000-01-19 2001-01-19 Use of pentosan polysulfate to treat certain conditions of the prostate Abandoned AU2001230994A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17708300P 2000-01-19 2000-01-19
US60/177,083 2000-01-19
PCT/US2001/001837 WO2001052867A1 (en) 2000-01-19 2001-01-19 Use of pentosan polysulfate to treat certain conditions of the prostate

Publications (1)

Publication Number Publication Date
AU2001230994A1 true AU2001230994A1 (en) 2001-07-31

Family

ID=22647123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230994A Abandoned AU2001230994A1 (en) 2000-01-19 2001-01-19 Use of pentosan polysulfate to treat certain conditions of the prostate

Country Status (4)

Country Link
US (2) US20020010140A1 (en)
AR (1) AR035026A1 (en)
AU (1) AU2001230994A1 (en)
WO (1) WO2001052867A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7453002B2 (en) * 2004-06-15 2008-11-18 Bristol-Myers Squibb Company Five-membered heterocycles useful as serine protease inhibitors
US7502229B2 (en) * 2004-10-15 2009-03-10 Alcatel Lucent Heat dissipation system for multiple integrated circuits mounted on a printed circuit board
DK2010220T3 (en) 2006-04-03 2022-05-23 Ceva Animal Health Pty Ltd STABILIZED PENTOSAN POLY SULPHATE (PPS) FORMULATIONS
AU2008100725B4 (en) 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd A sulfated polysaccharide compound for clinical use
US8871741B2 (en) * 2010-01-15 2014-10-28 Icahn School Of Medicine At Mount Sinai Inhibition of TNF-α induced activation of NFKB by pentosan polysulfate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
UA65587C2 (en) * 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus

Also Published As

Publication number Publication date
WO2001052867A9 (en) 2002-10-10
AR035026A1 (en) 2004-04-14
US6828309B2 (en) 2004-12-07
WO2001052867A1 (en) 2001-07-26
US20030040491A1 (en) 2003-02-27
US20020010140A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
EP1613251A4 (en) Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
EP1691760A4 (en) Devices systems, and methods to fixate tissue within the regions of the body, such as the pharyngeal conduit
HUP0500165A2 (en) Chalcone derivatives and their use to treat diseases
AU2001282717A1 (en) Cancer treatment by combination therapy
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
BRPI0010891B1 (en) generation of therapeutic microfoam.
AU3086900A (en) Device for the complex treatment of disorders of the prostate
AU2001272852A1 (en) Composition for the treatment of migraine
MXPA03000188A (en) Methods of treating neutrophil-related diseases with topical anesthetics.
AUPQ923100A0 (en) Treatment of prostate cancer
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
NO20022245L (en) Oncolytic combinations for the treatment of cancer
AU2001280804A1 (en) Aldosterone blocker therapy to prevent or treat inflammation-related disorders
MXPA03008634A (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases.
AU2003295336A1 (en) Use of etodoclac to treat hyperplasia
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
ZA200003236B (en) Combination therapy for the treatment of migraine.
AU2001266838A1 (en) Inhibitors of matriptase for the treatment of cancer
AU2002351374A1 (en) Antibodies to treat cancer
MXPA03007653A (en) Use of lp82 to treat hematopoietic disorders.
AU2001230994A1 (en) Use of pentosan polysulfate to treat certain conditions of the prostate
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU2001241630A1 (en) Treatment of inflammation with p20
ZA200002338B (en) Combination therapy for the treatment of migraine.